Home > Insider Trading > Filing (0001437749-22-009166)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
925741	Biocardia Inc.	BCDA;BCDAW	Biological Products, (No Disgnostic Substances) (2836)	232753988

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1647542	Peter Altman	C/O Biocardia, Inc. 320 Soquel Way Sunnyvale CA 94085	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-14	76,734	$0.00	314,643	No	4	A	Direct
Common Stock	Acquisiton	2022-04-18	13,500	$1.39	328,143	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2022-04-14	141,000	$0.00	141,000	$1.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
141,000		2032-04-14	No	4	A	Direct

Footnotes

The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
This transaction was executed in multiple trades ranging from $1.37 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.